-
Mashup Score: 5
Dr. Furqan shared data from a retrospective analysis on patients who received pirtobrutinib prior to CAR T-cell therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
Blood Cancers Today
Oncology / HematologyBlood Cancers Today is a property that provides hematologists and oncologists with news, education, and information relevant to their patients and practices, with insight from experts in the field. As the online home of the publication, bloodcancerstoday.com is updated daily, with the most current information from around the specialty and multimedia content, including exclusive interviews with presenters at major medical meetings.
At #ASCO24, @FateehaFurqan, a third-year oncology fellow at @MedicalCollege @MCWCancerCenter, shared data from a retrospective analysis on 11 patients who received pirtobrutinib prior to CAR-T therapy. #CLL 📺 Watch the full interview here! https://t.co/45CrOMx0Y8 https://t.co/HDdiUmgviP